SPONSORED CONTENT
For health systems and pharmacies participating in 340B, compliance is not optional. It is a core operational responsibility that affects audit readiness, pharmacy performance, and patient access. In a highly specialized environment shaped by regulatory scrutiny,
…SPONSORED CONTENT
As 2026 reaches its midpoint, 340B covered entities (CEs) are operating in an environment defined less by one sweeping policy change and more by the accumulation of operational pressure across the
…SPONSORED CONTENT
With numerous funding and policy changes underway amid a constantly evolving 340B landscape, the roles of chief financial officers (CFOs) and other financial leaders at covered entities (CEs) have become more challenging than ever.
As a former CFO of a CE
SPONSORED CONTENT
For many safety-net healthcare organizations, the 340B program represents more than a financial opportunity. When implemented thoughtfully, it can become a
…SPONSORED CONTENT
Verity Solutions is pleased to host a thought-provoking panel discussion ahead of the 340B Coalition Summer Conference, bringing together expert voices in 340B policy, compliance, and operations for a timely discussion on the
…SPONSORED CONTENT
2026 has already proven to be an incredibly turbulent year for 340B. As new state and federal regulations continue to take effect, many organizations may find their current 340B designation no longer accurately
…SPONSORED CONTENT
In the world of 340B, one thing is certain: change is constant. Every week seems to bring a new manufacturer restriction, operational challenge, compliance concern, or process update that impacts how covered entities manage their programs. Trying
…SPONSORED CONTENT
Across healthcare, AI deployment has become a dominant conversation — yet many organizations are still overlooking one of the most important and operationally complex opportunities: pharmacy. For health system–owned pharmacies and 340B programs,
…SPONSORED CONTENT
As HRSA’s proposed 340B rebate model moves to the White House Office of Management and Budget (OMB) for review, covered entities are once again preparing for what could become one of the most significant operational shifts in the modern
…SPONSORED CONTENT
The implementation of Medicare’s Maximum Fair Price (MFP) program under the Inflation Reduction Act has introduced one of the most operationally significant changes to pharmaceutical reimbursement in decades, one that has important ramifications for 340B
…